Baidu
map

Ophthalmic Epidemiol. :老年人群中年龄相关的眼睛疾病的流行率

2017-06-30 cuiguizhong MedSci原创

白内障是伊朗人口中最常见的与年龄相关的眼睛疾病,其次是年龄相关性黄斑变性。因此,精确规划以及强大的诊断和治疗设施是必要的。

近日,来自伊朗马什哈德医科大学眼科系的Yekta A教授团队在Ophthalmic Epidemiol.杂志上发表了他们的最近研究:老年人群中年龄相关的眼睛疾病的流行率。在本项研究中,作者们调查了伊朗54岁以上老年人对白内障、年龄相关性黄斑变性(AMD)、青光眼和糖尿病性视网膜病变(DR)等疾病的流行率。作者们通过随机抽样研究,在伊朗北部的萨里(Sari)选择了60个人群。在每个人群中,系统地选择了20位54岁以上的人,并邀请他们参加研究。入选后,所有参与者均进行了验光和眼科检查,包括裂隙灯生物显微镜和眼底镜检查。研究结果显示,在1185名选定人员中,937名(79.1%)参加了本研究(年龄范围55-87岁)。在这些人中,至少一只眼睛患白内障、年龄相关性黄斑变性、青光眼和糖尿病性视网膜病变的患病率分别为为29.6%(95%置信区间[ confidence interval,CI] 26.6-32.5)、5.8%(95% CI:4.3-7.3)、3.7%(95% CI :2.5-5.0)和2.7%(95%CI :1.6-3.7)。这些疾病的流行率随老龄化而显着增加。 年龄相关性黄斑变性在

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1933417, encodeId=4be8193341ece, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 04 18:19:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720730, encodeId=a85a1e2073099, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Tue Feb 27 04:19:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526731, encodeId=99071526e3187, content=<a href='/topic/show?id=f37e8012213' target=_blank style='color:#2F92EE;'>#老年人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80122, encryptionId=f37e8012213, topicName=老年人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541223, encodeId=a890154122313, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1933417, encodeId=4be8193341ece, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 04 18:19:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720730, encodeId=a85a1e2073099, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Tue Feb 27 04:19:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526731, encodeId=99071526e3187, content=<a href='/topic/show?id=f37e8012213' target=_blank style='color:#2F92EE;'>#老年人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80122, encryptionId=f37e8012213, topicName=老年人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541223, encodeId=a890154122313, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=)]
    2018-02-27 lixiaol
  3. [GetPortalCommentsPageByObjectIdResponse(id=1933417, encodeId=4be8193341ece, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 04 18:19:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720730, encodeId=a85a1e2073099, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Tue Feb 27 04:19:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526731, encodeId=99071526e3187, content=<a href='/topic/show?id=f37e8012213' target=_blank style='color:#2F92EE;'>#老年人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80122, encryptionId=f37e8012213, topicName=老年人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541223, encodeId=a890154122313, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1933417, encodeId=4be8193341ece, content=<a href='/topic/show?id=79654901349' target=_blank style='color:#2F92EE;'>#年龄相关#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49013, encryptionId=79654901349, topicName=年龄相关)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Tue Jul 04 18:19:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720730, encodeId=a85a1e2073099, content=<a href='/topic/show?id=a7ff65385f1' target=_blank style='color:#2F92EE;'>#流行率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65385, encryptionId=a7ff65385f1, topicName=流行率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d44c32960238, createdName=lixiaol, createdTime=Tue Feb 27 04:19:00 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526731, encodeId=99071526e3187, content=<a href='/topic/show?id=f37e8012213' target=_blank style='color:#2F92EE;'>#老年人群#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80122, encryptionId=f37e8012213, topicName=老年人群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541223, encodeId=a890154122313, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Sun Jul 02 11:19:00 CST 2017, time=2017-07-02, status=1, ipAttribution=)]

相关资讯

J VIRAL HEPATITIS:中国农村近两百万备孕夫妇乙肝流行率现状

乙型肝炎病毒(HBV)感染是导致全球高死亡率和社会负担的主要健康问题。全球估计有20亿人感染HBV,其中2.46亿人为慢性感染,发生肝功能失代偿、肝硬化和肝细胞癌的风险增加。更为重要的是,中国的HBV感染负担居世界之最,估计有7460万HBsAg携带者。尽管过去二十年间,中国从HBV高流行率降至中度流行率,但HBV感染人群的绝对数量仍然非常大。尽管成功实施了婴幼儿普遍乙型肝炎疫苗接种计划,中国一直

中国高血压患者合并糖尿病较常见

  我国北京安贞医院研究人员在2012年世界心脏病学大会(4月18~21日,阿联酋迪拜)上公布的一项研究显示:虽然我国高血压患者的糖尿病流行率较高,但是,即便他们正在接受糖尿病治疗,其糖尿病知晓率仍很低。此外,高血压合并糖尿病的患者的降血糖治疗率和血糖达标率均很低。研究人员认为:在接受治疗的中国高血压患者中,强调血糖检测的重要性和提高护理质量很重要。   此项横断面调查样本来自2009年中

Baidu
map
Baidu
map
Baidu
map